Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

BioFire Respiratory Panel 2.1 Recalled for False Negative Risk

Agency Publication Date: November 26, 2025
Share:
Sign in to monitor this recall

Summary

BioFire Diagnostics, LLC is recalling 23 kits (690 pouches) of the BioFire Respiratory Panel 2.1, an in vitro diagnostic test. The recall was issued because chemicals inside the test pouch can move unexpectedly, which may cause the panel to produce false negative results or suffer from control failures. This recall affects the 30-test kit with catalog number REF: 423742 and Lot # 2649724. You should contact the manufacturer or your distributor to arrange for the return or replacement of any affected kits in your inventory.

Risk

The unintended movement of chemistry within the test pouch can cause the test to provide a negative result even when a pathogen is present. This risk of false negatives could lead to delayed or incorrect medical treatment for respiratory infections and potentially contribute to the further spread of illness.

What You Should Do

  1. The recalled products are BioFire Respiratory Panel 2.1 (30 test kits) labeled with catalog number REF: 423742, Lot # 2649724, and UDI: 00815381020529.
  2. Identify affected kits by checking the REF and Lot numbers printed on the outer packaging of the test kit.
  3. Stop using the recalled test kits immediately to prevent the risk of reporting inaccurate patient results.
  4. Contact BioFire Diagnostics, LLC or your medical supply distributor to arrange for the return, replacement, or correction of the affected product.
  5. Call the FDA at 1-888-463-6332 (1-888-INFO-FDA) for additional questions regarding this recall.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled product. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: BioFire Respiratory Panel 2.1, IVD (30 test kit)
Variants: 30 test kit
Model / REF:
423742
Lot Numbers:
2649724
UDI:
00815381020529

Recall involves 23 kits total, equaling 690 individual pouches.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97870
Status: Active
Manufacturer: BioFire Diagnostics, LLC
Sold By: Medical distributors; Laboratory suppliers
Manufactured In: United States
Units Affected: 23 kits (690 pouches)
Distributed To: Idaho, Oregon, Arizona

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.